Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bone metastasis is the third most common condition in metastatic cancers and occurs in 60-65% of patients with metastatic cancers. The spine is the most common site of bone metastasis. Other common sites include ribs, skull, pelvis (hip bone), femur (leg bone) and humerus (arm bone). Bone metastatic cancers are rarely able to be cured, and treatment of bone metastasis involves medications to shrink, stop or slow down the growth of the tumor. Treatment options available for bone metastasis are symptomatic treatments which are meant for pain control, treatment, and prevention of fractures, improvement in functional disability, etc. Randomized trials on metastatic patients by UBM Medica, LLC showed that 45-75% patients develop functional disability every 3-4 months, 10-15% patients develop hypercalcemia and 10-20% patients develop long bone fractures.
Treatment of bone metastasis is the interdisciplinary field involving pain management, orthopedics, and other medical specialties. Primary factors driving the growth of bone metastasis therapeutics market are the global increase in cancer prevalence and delayed diagnosis of cancer in low-income countries. According to University of Texas Southwestern Medical Center Dallas, over 600,000 of bone metastasis are diagnosed in the U.S. every year. Rapid innovation in the field of personalized medicine and identification of new therapeutic targets for bone metastasis presents a huge opportunity to manufacturers of targeted therapy agents. A large number of treatment methods are still under investigation. However, heterogeneous nature of cancer and high development cost of neoplastic agents are the factors limiting the growth of global bone metastasis therapeutics market.
The report details the trend, potential and market size of Bone Metastasis Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bone Metastasis Therapeuticsmarket, defines the market attractiveness level of Bone Metastasis Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bone Metastasis Therapeutics industry, describes the types of Bone Metastasis Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bone Metastasis Therapeutics market and the development prospects and opportunities of Bone Metastasis Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bone Metastasis Therapeutics market in Chapter 13.
By Player:
F Hoffmann-La Roche
Bayer
Merck
By Type:
Drug Treatment
Tumor Ablation Therapy
Surgery
By End-User:
Hospitals
Cancer Rehabilitation Centers
Specialty Clinics
Ambulatory Surgical Centers
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bone Metastasis Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bone Metastasis Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bone Metastasis Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bone Metastasis Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bone Metastasis Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Bone Metastasis Therapeutics Consumption (2017-2022)
-
7.2 United States Bone Metastasis Therapeutics Consumption (2017-2022)
-
7.3 Europe Bone Metastasis Therapeutics Consumption (2017-2022)
-
7.4 China Bone Metastasis Therapeutics Consumption (2017-2022)
-
7.5 Japan Bone Metastasis Therapeutics Consumption (2017-2022)
-
7.6 India Bone Metastasis Therapeutics Consumption (2017-2022)
-
7.7 South Korea Bone Metastasis Therapeutics Consumption (2017-2022)
8 Region and Country-wise Bone Metastasis Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Bone Metastasis Therapeutics Consumption Forecast (2022-2028)
9 Global Bone Metastasis Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Bone Metastasis Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Drug Treatment Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Tumor Ablation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Surgery Consumption and Growth Rate (2017-2022)
-
9.2 Global Bone Metastasis Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Cancer Rehabilitation Centers Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
10 Global Bone Metastasis Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Bone Metastasis Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Tumor Ablation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bone Metastasis Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Cancer Rehabilitation Centers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
11 Global Bone Metastasis Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bone Metastasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bone Metastasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bone Metastasis Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bone Metastasis Therapeutics Market Competitive Analysis
-
14.1 F Hoffmann-La Roche
-
14.1.1 F Hoffmann-La Roche Company Details
-
14.1.2 F Hoffmann-La Roche Bone Metastasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 F Hoffmann-La Roche Bone Metastasis Therapeutics Product and Service
-
14.2 Bayer
-
14.2.1 Bayer Company Details
-
14.2.2 Bayer Bone Metastasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Bayer Bone Metastasis Therapeutics Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Bone Metastasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Bone Metastasis Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bone Metastasis Therapeutics
-
Figure Bone Metastasis Therapeutics Picture
-
Table Global Bone Metastasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bone Metastasis Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bone Metastasis Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bone Metastasis Therapeutics Consumption by Country (2017-2022)
-
Figure United States Bone Metastasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Bone Metastasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Bone Metastasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Bone Metastasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Bone Metastasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bone Metastasis Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Metastasis Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Bone Metastasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bone Metastasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bone Metastasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bone Metastasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bone Metastasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bone Metastasis Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Tumor Ablation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Surgery Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Rehabilitation Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Specialty Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Ambulatory Surgical Centers Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tumor Ablation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Surgery Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Rehabilitation Centers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Specialty Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ambulatory Surgical Centers Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bone Metastasis Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bone Metastasis Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table F Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table F Hoffmann-La Roche Bone Metastasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Bone Metastasis Therapeutics Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Bone Metastasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Bone Metastasis Therapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Bone Metastasis Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Bone Metastasis Therapeutics Product and Service
-
